The PROACT Trial
March 5, 2025 | Talking with C. Michael Gibson, David Austin reviews the phase III trial of enalapril for anthracycline-induced cardiotoxicity in lymphoma and breast cancer patients. |
New at TCTMD? Register today!
Enter the email you used to register to reset your password.